Neutrophil gelatinase-associated lipocalin (NGAL) predicts response to neoadjuvant chemotherapy and clinical outcome in primary human breast cancer.

by Antonia Sophie Wenners, Keyur Mehta, Sibylle Loibl, Hyerim Park, Berit Mueller, Norbert Arnold, Sigrid Hamann, Joerg Weimer, Beyhan Ataseven, Silvia Darb-Esfahani, Christian Schem, Christoph Mundhenke, Fariba Khandan, Christoph Thomssen, Walter Jonat, Hans-Juergen Holzhausen, Gunther von Minckwitz, Carsten Denkert, Maret Bauer
Published 2012-01-01